The type of sensitizing allergen can affect the evolution of respiratory allergy

被引:30
作者
Marogna, M.
Massolo, A.
Berra, D.
Zanon, P.
Chiodini, E.
Canonica, G. W.
Passalacqua, G.
机构
[1] Univ Genoa, I-16132 Genoa, Italy
[2] Macchi Hosp Fdn, Pneumol Unit, Varese, Italy
[3] Univ Florence, Dept Anim Biol & Genet, I-50121 Florence, Italy
[4] Busto Arsizio Hosp, Pneumol Unit, Genoa, Italy
[5] Busto Arsizio Hosp, Nucl Med Unit, Genoa, Italy
关键词
asthma; bronchial hyperreactivity; evolution; rhinitis; sensitization;
D O I
10.1111/j.1398-9995.2006.01164.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Numerous factors affect the evolution of respiratory allergy, in children, but little is known in adults. We assessed in a prospective study the influence of the type of allergen on the progression of disease. Methods: Outpatients, with respiratory allergy underwent skin tests and pulmonary function/methacholine challenge at baseline and after 3 years. Patients were subdivided in pure rhinitis or rhinitis + bronchial hyperreactivity (BHR). In polysensitized subjects a single relevant allergen (mites, grasses, birch, Parietaria) was identified based on symptom distribution and when needed on nasal challenge. Results: 6750 patients (age range 12-46) were studied. Of them, 17.8% were monosensitized but this percentage decreased to 10.4% after 3 years (P < 0.05). Subjects with pure rhinitis were 81% at the beginning and 48% at the end. After 3 years, the patients with bronchial responsiveness increased from 18% to 58% for mites, 22% to 49% for birch, 18% to 44% for grasses, 17% to 32% for Parietaria, with a significant difference among allergens (P < 0.05). Almost the same was seen in monosensitized subjects, being mites most likely to cause a worsening. All patients with BHR at baseline received immunotherapy. In these patients the onset of new sensitizations was significantly lower than in the group (pure rhinitis) receiving drugs only and lower airways symptoms disappeared more frequently. Conclusion: The different type of allergen influences the course of the disease, as well as the use of immunotherapy.
引用
收藏
页码:1209 / 1215
页数:7
相关论文
共 27 条
[1]   An update on the asthma-rhinitis link [J].
Passalacqua, Giovanni ;
Ciprandi, Giorgio ;
Pasquali, Mercedes ;
Guerra, Laura ;
Canonica, Giorgio Walter .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 4 (03) :177-183
[2]   Allergic rhinitis and its impact on asthma [J].
Bousquet, J ;
van Cauwenberge, P ;
Khaltaev, N ;
Ait-Khaled, N ;
Annesi-Maesano, I ;
Bachert, C ;
Baena-Cagnani, C ;
Bateman, E ;
Bonini, S ;
Canonica, GW ;
Carlsen, KH ;
Demoly, P ;
Durham, SR ;
Enarson, D ;
Fokkens, WJ ;
van Wijk, RG ;
Howarth, P ;
Ivanova, NA ;
Kemp, JP ;
Klossek, JM ;
Lockey, RF ;
Lund, V ;
Mackay, I ;
Malling, HJ ;
Meltzer, EO ;
Mygind, N ;
Okunda, M ;
Pawankar, R ;
Price, D ;
Scadding, GK ;
Simons, FER ;
Szczeklik, A ;
Valovirta, E ;
Vignola, AM ;
Wang, DY ;
Warner, JO ;
Weiss, KB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (05) :S147-S334
[3]   Airway hyperresponsiveness: From molecules to bedside - Invited review: Complexity of factors modulating airway narrowing in vivo: relevance to assessment of airway hyperresponsiveness [J].
Brusasco, V ;
Pellegrino, R .
JOURNAL OF APPLIED PHYSIOLOGY, 2003, 95 (03) :1305-1313
[4]   TERFENADINE EXERTS ANTIALLERGIC ACTIVITY REDUCING ICAM-I EXPRESSION ON NASAL EPITHELIAL-CELLS IN PATIENTS WITH POLLEN ALLERGY [J].
CIPRANDI, G ;
PRONZATO, C ;
RICCA, V ;
VARESE, P ;
DELGIACCO, GS ;
CANONICA, GW .
CLINICAL AND EXPERIMENTAL ALLERGY, 1995, 25 (09) :871-878
[5]   The effect of allergen exposure in early childhood on the development of atopy [J].
Custovic A. ;
Murray C.S. .
Current Allergy and Asthma Reports, 2002, 2 (5) :417-423
[6]   The natural course of allergic rhinitis during 12 years of follow-up [J].
Danielsson, J ;
Jenssen, M .
ALLERGY, 1997, 52 (03) :331-334
[7]   Pollen and eosinophilic esophagitis [J].
Fogg, MI ;
Ruchelli, E ;
Spergel, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (04) :796-797
[8]  
Good P., 2000, PERMUTATION TESTS PR
[9]  
Hosmer D. W. J., 2001, APPL LOGISTIC REGRES
[10]  
Kalliomaki M., 2002, Current Drug Targets - Infectious Disorders, V2, P193